Literature DB >> 27137426

Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Samuele Cortese1, Stephen V Faraone, Silvia Bernardi, Shuai Wang, Carlos Blanco.   

Abstract

BACKGROUND: Gaining insight into possible gender differences in the clinical presentation of adults with attention-deficit/hyperactivity disorder (ADHD) is of relevance in order to conduct appropriate screening and treatment interventions in both genders.
METHOD: The analyses compared (1) prevalence and sociodemographic correlates, (2) frequency of ADHD core symptoms, (3) rates of subtypes, (4) prevalence of comorbid mental health conditions, and (5) rates of risky/impulsive behaviors, as well as health and social correlates, in men and women with ADHD in a nationally representative, US population-based sample. Face-to-face psychiatric interviews were conducted according to DSM-IV criteria in 34,653 adults from the US National Epidemiologic Survey on Alcohol and Related Conditions (Wave 2, 2004-2005).
RESULTS: While the prevalence of lifetime ADHD was significantly higher in men than in women (OR = 1.46, 95% CI = 1.22-1.76), the rate of persistent ADHD did not significantly differ across genders (OR = 1.23, 95% CI = 0.96-1.58). Compared to men with persistent ADHD, women with persistent ADHD, despite having lower rates of hyperactive symptoms, presented with similar ADHD subtypes profile and rates of risky behaviors (except for reckless driving), as well as with significantly more anxiety and perceived mental health impairment (P = .032). Results were similar when considering lifetime ADHD.
CONCLUSIONS: Our findings show that, despite different symptom profiles and comorbidities, men and women have similar rates of current ADHD and of risky behaviors associated with the disorder. Women with ADHD should receive as much attention as their male counterparts. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27137426     DOI: 10.4088/JCP.14m09630

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  Effectiveness of a Tailored Intervention for Women With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD Symptoms: A Randomized Controlled Study.

Authors:  Sharon A Gutman; Sheetala Balasubramanian; Maya Herzog; Elizabeth Kim; Hannah Swirnow; Yudis Retig; Samantha Wolff
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

Review 2.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

3.  ADHD Comorbidity Structure and Impairment: Results of the WHO World Mental Health Surveys International College Student Project (WMH-ICS).

Authors:  Arthur D P Mak; Sue Lee; Nancy A Sampson; Yesica Albor; Jordi Alonso; Randy P Auerbach; Harald Baumeister; Corina Benjet; Ronny Bruffaerts; Pim Cuijpers; David D Ebert; Raúl A Gutierrez-Garcia; Penelope Hasking; Coral Lapsley; Christine Lochner; Ronald C Kessler
Journal:  J Atten Disord       Date:  2021-11-10       Impact factor: 3.196

4.  National Patterns of Commonly Prescribed Psychotropic Medications to Young People.

Authors:  Ryan S Sultan; Christoph U Correll; Michael Schoenbaum; Marrisa King; John T Walkup; Mark Olfson
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-01-29       Impact factor: 2.576

Review 5.  Sex differences in stress reactivity in arousal and attention systems.

Authors:  Debra A Bangasser; Samantha R Eck; Evelyn Ordoñes Sanchez
Journal:  Neuropsychopharmacology       Date:  2018-06-29       Impact factor: 7.853

6.  Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement.

Authors:  Aditi Bhargava; Arthur P Arnold; Debra A Bangasser; Kate M Denton; Arpana Gupta; Lucinda M Hilliard Krause; Emeran A Mayer; Margaret McCarthy; Walter L Miller; Armin Raznahan; Ragini Verma
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 25.261

7.  Validation of an EMR algorithm to measure the prevalence of ADHD in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN).

Authors:  Rachael Morkem; Kenneth Handelman; John A Queenan; Richard Birtwhistle; David Barber
Journal:  BMC Med Inform Decis Mak       Date:  2020-07-20       Impact factor: 2.796

8.  Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.

Authors:  Winston Chung; Sheng-Fang Jiang; Diana Paksarian; Aki Nikolaidis; F Xavier Castellanos; Kathleen R Merikangas; Michael P Milham
Journal:  JAMA Netw Open       Date:  2019-11-01

9.  Gender differences in adult ADHD: Cognitive function assessed by the test of attentional performance.

Authors:  Tina Stibbe; Jue Huang; Madlen Paucke; Christine Ulke; Maria Strauss
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

10.  Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women.

Authors:  Susan Young; Nicoletta Adamo; Bryndís Björk Ásgeirsdóttir; Polly Branney; Michelle Beckett; William Colley; Sally Cubbin; Quinton Deeley; Emad Farrag; Gisli Gudjonsson; Peter Hill; Jack Hollingdale; Ozge Kilic; Tony Lloyd; Peter Mason; Eleni Paliokosta; Sri Perecherla; Jane Sedgwick; Caroline Skirrow; Kevin Tierney; Kobus van Rensburg; Emma Woodhouse
Journal:  BMC Psychiatry       Date:  2020-08-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.